OpenText is one of our favourite legacy tech stocks, National Bank says

Enterprise software company OpenText (OpenText Stock Quote, Chart, News TSX:OTEX) gets high praise from National Bank Financial analyst Richard Tse but the stock and company are likely to do better over the long-run than over the COVID-19 era.

In an update to clients on April 8, Tse kept his “Outperform” rating for OTEX but dropped his target from $55.00 to $45.00, representing at press time a projected 12-month total return of 25 per cent.

Waterloo, Ontario-headquartered OpenText held its Enterprise World Europe conference on Wednesday in a virtual format, drawing over 2,500 participants as the company announced the release of OpenText’s CE 20.2, the cloud-native version of OpenText’s suite of information management applications, and its new Trading Grid cloud integration services platform.

“COVID-19 changes everything, and industries are experiencing massive disruption in their approach to materials, manufacturing and supply chain strategy,” said CEO & CTO Mark J. Barrenechea in a press release. “Our new OpenText Business Network 20.2 responds to these radical shifts. Our new unified platform solves for this complexity by vertically integrating all aspects of the modern supply chain, including EDI, ERP and new Cloud services and APIs.”

Tse attended the online event and while unable to speak to customers and partners in person the analyst came away feeling good about OTEX’s long-term position with CE 20.2.

“We see the release as firmly pivoting OpenText towards an increasingly recurring revenue base while making it easier to drive organic growth given an integrated suite of applications and services in the cloud,” Tse wrote.

“Of course, while the above is positive to supporting our investment thesis (longer term), the hard reality is we won’t likely see the full benefit of today’s product announcements for some time given the current global backdrop,” Tse said.

Tse said even though the current climate has upped the risk profile for many companies including OTEX, the company is on solid footing, pointing to the company’s strong balance sheet bolstered by 80 per cent recurring revenue and a cash flow profile of $594 million in free cash flow in fiscal 2020.

More specifically, during the COVID-19 pandemic Tse pointed out that while OTEX’s solutions don’t necessarily target the current work-from-home boom, its recent major purchase in Carbonite is helpful in that it came with Carbonite’s BrightCloud Threat Intelligence. useful in the current high-online traffic environment.

Tse also pointed to OpenText’s portfolio of telecommuting support solutions such as OpenText Exceed

TurboX, OpenText Carbonite O365 MS Teams Backup and Core share and Signature, all remote work applications.

“Bottom line, our view on OTEX is unchanged. Investors following our research will know it remains one of our favourite ‘legacy’ names. We continue to see relative value with some compelling defensive attributes at this point. We see a growing base of recurring revenue through acquisitions, expanding operating leverage and optionality from organic growth,” Tse added.

For 2020, Tse thinks OTEX will generate revenue and EBITDA of $2.96 billion and $1.05 billion, respectively, and 2021 revenue and EBITDA of $3.17 billion and $1.17, respectively. (All figures in US dollars.)

We Hate Paywalls Too!

At Cantech Letter we prize independent journalism like you do. And we don't care for paywalls and popups and all that noise That's why we need your support. If you value getting your daily information from the experts, won't you help us? No donation is too small.

Make a one-time or recurring donation

Tagged with: otex
Jayson MacLean

Jayson is a writer, researcher and educator with a PhD in political philosophy from the University of Ottawa. His interests range from bioethics and innovations in the health sciences to governance, social justice and the history of ideas.

Recent Posts

WELL Health inks five-year deal with Microsoft

It's become one of the biggest players in the Canadian healthcare space, now WELL Health (WELL Health Stock Quote, Chart,… [Read More]

15 hours ago

Is Thomson Reuters stock a buy right now?

Its stock has made a since last October, but is there more upside left in Thomson Reuters (Thomson Reuters Stock… [Read More]

16 hours ago

Is GOOGL still a buy?

Following a widely applauded first quarter beat, Roth MKM analyst Rohit Kulkarni has maintained his "Buy" rating on Alphabet (Alphabet… [Read More]

2 days ago

NLH has 173% upside, Echelon says

Following an acquisition, Echelon Capital Markets analyst Stefan Quenneville has maintained his "Buy" rating on Nova Leap Health (Nova Leap… [Read More]

2 days ago

Shopify upgraded to “Buy” at Citi

The stock has been flat since November, but Citi analyst Tyler Radke thinks there is now money to be made… [Read More]

2 days ago

Sabio has 400% upside, Eight Capital says

Following the company's fourth quarter results, Eight Capital analyst Kiran Sritharan has maintained his "Buy" rating on Sabio Holdings (Sabio… [Read More]

4 days ago